ANGPT2 and neoplasm: To this aim, we administered A2V (a bispecific antibody against angiopoietin-2 and VEGFA44) and PD1 antibodies, or irrelevant IgGs, to mice 15 days post-tumor inoculation, and examined lung tumor growth at day 28 using micro-CT imaging.